Nine men completed a 24-h exercise trial, with physiological testing sessions before (T1, ϳ0630), during (T2, ϳ1640; T3, ϳ0045; T4, ϳ0630), and 48-h afterwards (T5, ϳ0650). Participants cycled and ran/trekked continuously between test sessions. A 24-h sedentary control trial was undertaken in crossover order. Within testing sessions, participants lay supine and then stood for 6 min, while heart rate variability (spectral analysis of ECG), middle cerebral artery perfusion velocity (MCAv), mean arterial pressure (MAP; Finometer), and end-tidal PCO2 (PETCO 2 ) were measured, and venous blood was sampled for cardiac troponin I. During the exercise trial: 1) two, six, and four participants were orthostatically intolerant at T2, T3, and T4, respectively; 2) changes in heart rate variability were only observed at T2; 3) supine MAP (baseline ϭ 81 Ϯ 6 mmHg) was lower (P Ͻ 0.05) by 14% at T3 and 8% at T4, whereas standing MAP (75 Ϯ 7 mmHg) was lower by 16% at T2, 37% at T3, and 15% at T4; 4) PETCO 2 was reduced (P Ͻ 0.05) at all times while supine (Ϫ3-4 Torr) and standing (Ϫ4 -5 Torr) during exercise trial; 5) standing MCAv was reduced (P Ͻ 0.05) by 23% at T3 and 30% at T4 during the exercise trial; 6) changes in MCAv with standing always correlated (P Ͻ 0.01) with changes in PETCO 2 (r ϭ 0.78 -0.93), but only with changes in MAP at T1, T2, and T3 (P Ͻ 0.05; r ϭ 0.62-0.84); and 7) only two individuals showed minor elevations in cardiac troponin I. Recovery was complete within 48 h. During prolonged exercise, posturalinduced hypotension and hypocapnia exacerbate cerebral hypoperfusion and facilitate syncope.